Pharmala Biotech Holdings Inc. (MDMA.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 02-2026 | 11-2025 | 08-2025 | 05-2025 | 02-2025 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 30 | 30 | 29 | 29 | 29 |
| Accounts receivable | -42 | -116 | -139 | 8 | 30 |
| Other Working Capital | -76 | 115 | -88 | 41 | 71 |
| Other Operating Activity | -162 | -145 | -97 | -335 | -383 |
| Operating Cash Flow | $-250 | $-116 | $-295 | $-257 | $-253 |
| Cash Flows From Investing Activities | |||||
| Sale Of Investment | 850 | 170 | 215 | N/A | N/A |
| Purchase Sale Intangibles | -20 | -11 | -4 | -7 | 4 |
| Other Investing Activity | -550 | 0 | -3 | 129 | -1,244 |
| Investing Cash Flow | $280 | $160 | $208 | $121 | $-1,241 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | -3 | 0 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | 1,560 |
| Financing Cash Flow | $0 | $0 | $-3 | $0 | $1,560 |
| Beginning Cash Position | 84 | 40 | 130 | 265 | 199 |
| End Cash Position | 113 | 84 | 40 | 130 | 265 |
| Net Cash Flow | $30 | $43 | $-90 | $-136 | $67 |
| Free Cash Flow | |||||
| Operating Cash Flow | -250 | -116 | -295 | -257 | -253 |
| Capital Expenditure | -20 | -11 | -7 | -7 | N/A |
| Free Cash Flow | -270 | -127 | -302 | -264 | -253 |